Cargando…

Liver injury in COVID-19: The current evidence

Patients with novel coronavirus disease 2019 (COVID-19) experience various degrees of liver function abnormalities. Liver injury requires extensive work-up and continuous surveillance and can be multifactorial and heterogeneous in nature. In the context of COVID-19, clinicians will have to determine...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alqahtani, Saleh A, Schattenberg, Jörn M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Review Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7268949/ https://www.ncbi.nlm.nih.gov/pubmed/32450787 http://dx.doi.org/10.1177/2050640620924157

Ejemplares similares

NAFLD in the Elderly
por: Alqahtani, Saleh A, et al.
Publicado: (2021)

Abnormal Liver Biochemistry Tests and Acute Liver Injury in COVID-19 Patients: Current Evidence and Potential Pathogenesis
por: McGrowder, Donovan A., et al.
Publicado: (2021)

Beyond the Paradigm of Weight Loss in Non-Alcoholic Fatty Liver Disease: From Pathophysiology to Novel Dietary Approaches
por: Armandi, Angelo, et al.
Publicado: (2021)

COVID-19 combined with liver injury: Current challenges and management
por: Deng, Man-Ling, et al.
Publicado: (2021)

Significant liver fibrosis is a predictor of poor health-related quality of life in people living with HIV
por: Michel, Maurice, et al.
Publicado: (2022)

Nutritional Intake and the Risk for Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

The global fatty liver disease Sustainable Development Goal country score for 195 countries and territories
por: Lazarus, Jeffrey V., et al.
Publicado: (2023)

The Impact of Liver Cell Injury on Health-Related Quality of Life in Patients with Chronic Liver Disease
por: Alt, Yvonne, et al.
Publicado: (2016)

COVID-19 and Indirect Liver Injury: A Narrative Synthesis of the Evidence
por: Idalsoaga, Francisco, et al.
Publicado: (2021)

Assessing the disease burden of non-alcoholic fatty liver disease in the real world – big data and big numbers
por: Schattenberg, Jörn M., et al.
Publicado: (2019)

The Intersection of COVID-19 and Metabolic-Associated Fatty Liver Disease: An Overview of the Current Evidence
por: Buchynskyi, Mykhailo, et al.
Publicado: (2023)

Refining imaging tools to detect advanced fibrosis: could liver surface nodularity address an unmet need in the NAFLD epidemic?
por: Schattenberg, Jörn M., et al.
Publicado: (2022)

Pathogenetic Mechanisms of Liver-Associated Injuries, Management, and Current Challenges in COVID-19 Patients
por: Naeem, Muhammad, et al.
Publicado: (2023)

COVID-19 Vaccines and Myocarditis: An Overview of Current Evidence
por: Hromić-Jahjefendić, Altijana, et al.
Publicado: (2023)

COVID-19-Associated Liver Injury
por: Gildea, Daniel T, et al.
Publicado: (2023)

Imaging of COVID-19: An update of current evidences
por: Kato, Shingo, et al.
Publicado: (2021)

Regulation of the effects of CYP2E1-induced oxidative stress by JNK signaling
por: Schattenberg, Jörn M., et al.
Publicado: (2014)

The Impact of COVID-19 on Liver Injury
por: Dawood, Dr. Reham M., et al.
Publicado: (2022)

Hypertension and COVID-19: Current Evidence and Perspectives
por: Gallo, Giovanna, et al.
Publicado: (2022)

Reversal of liver cirrhosis: current evidence and expectations
por: Jung, Young Kul, et al.
Publicado: (2017)

Incident Dementia in Elderly Patients with Nonalcoholic Fatty Liver Disease in Germany
por: Labenz, Christian, et al.
Publicado: (2020)

Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis: The Patient and Physician Perspective
por: Eskridge, Wayne, et al.
Publicado: (2023)

Radiation-induced lung injury: current evidence
por: Arroyo-Hernández, Marisol, et al.
Publicado: (2021)

Referral care paths for non‐alcoholic fatty liver disease—Gearing up for an ever more prevalent and severe liver disease
por: van Dijk, Anne‐Marieke, et al.
Publicado: (2021)

Current evidence on posthepatectomy liver failure: comprehensive review
por: Sparrelid, Ernesto, et al.
Publicado: (2022)

COVID-19 and liver injury: An ongoing challenge
por: Papagiouvanni, Ioanna, et al.
Publicado: (2023)

Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study
por: Pfirrmann, Daniel, et al.
Publicado: (2019)

The Snoring Index Identifies Risk of Non-Alcoholic Fatty Liver Disease in Patients with Obstructive Sleep Apnea Syndrome
por: Bahr, Katharina, et al.
Publicado: (2021)

COVID-19 pandemic: A review based on current evidence
por: Mahalmani, Vidya M., et al.
Publicado: (2020)

Diabetes and COVID-19: A systematic review on the current evidences
por: Abdi, Alireza, et al.
Publicado: (2020)

Potential therapeutic options for COVID-19: an update on current evidence
por: Niknam, Zahra, et al.
Publicado: (2022)

Efficacy of tocilizumab in COVID-19: A review of the current evidence
por: Alam, Walid, et al.
Publicado: (2021)

Impact of thyroid disorders on the incidence of non‐alcoholic fatty liver disease in Germany
por: Labenz, Christian, et al.
Publicado: (2021)

COVID-19: An overview and a clinical update
por: Krishnan, Arunkumar, et al.
Publicado: (2021)

Adipokines and Endotoxemia Correlate with Hepatic Steatosis in Non-Alcoholic Fatty Liver Disease (NAFLD)
por: Nier, Anika, et al.
Publicado: (2020)

Vitamins, supplements and COVID-19: a review of currently available evidence
por: Speakman, Lauren L, et al.
Publicado: (2021)

Remdesivir – Current evidence & perspective in management of COVID-19 infection
por: Bajpai, Jyoti, et al.
Publicado: (2021)

Novel Evidence of Acute Kidney Injury in COVID-19
por: Chueh, Ti-I, et al.
Publicado: (2020)

COVID-19: Gastrointestinal manifestations, liver injury and recommendations
por: Ozkurt, Zulal, et al.
Publicado: (2022)

COVID-19 and liver injury in individuals with obesity
por: Lempesis, Ioannis G, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_4tn821nqjbapt136bpi024gsin